A mammary-specific model demonstrates the role of the p53 tumor suppressor gene in tumor development

Oncogene

Volumn 19, Issue 8, 2000, Pages 1052-1058

  Jerry, D J ^a   Kittrell, F S ^b   Kuperwasser, C ^a   Laucirica, R ^b   Dickinson, E S ^a   Bonilla, P J ^b   Butel, J S ^b   Medina, D ^b  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Carcinogenesis; DMBA; Hormonal stimulation; Knockout mice; p53; Tumor incidence

Indexed keywords

DIMETHYLBENZ[A]ANTHRACENE; PROTEIN P53;

ANEUPLOIDY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST ADENOCARCINOMA; BREAST CARCINOGENESIS; BREAST EPITHELIUM; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; FEMALE; GENE MUTATION; HORMONAL REGULATION; HUMAN; HYPOPHYSIS GRAFT; MOUSE; NONHUMAN; PHENOTYPE; PREGNANCY; PRIORITY JOURNAL; THYMUS LYMPHOMA; TUMOR SUPPRESSOR GENE;

ANIMALIA; RODENTIA;

EID: 0034696344     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1203270     Document Type: Article

References (40)

1. Amundadottir LT, Johnson MD, Merlino G, Smith GH and Dickson RB. (1995). Cell Growth Differ., 6, 737-748.
2. Bouffler SD, Kemp CJ, Balmain A and Cox R. (1995). Cancer Res., 55, 3883-3889.
3. Cardiff RD and Wellings SR. (1999). J. Mammary Gland Biol. Neoplasia, 4, 105-122.
4. Christov K, Swanson SM, Guzman RC, Thordarson G, Jin E, Talamantes F and Nandi S. (1993). Carcinogenesis, 14, 2019-2025.
5. Coles C, Condie A, Chetty U, Steel CM, Evans HJ and Prosser J. (1992). Cancer Res., 52, 5291-5298.
6. Delmolino L, Band H and Band V. (1993). Carcinogenesis, 14, 827-832.
7. Donehower LA, Godley LA, Aldaz CM, Pyle R, Shi Y-P, Pinkel D, Gray J, Bradley A, Medina D and Varmus HE. (1995). Genes Dev., 9, 882-895.
8. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA, Butel JS and Bradley A. (1992). Nature, 356, 215-221.
9. Elledge RM and Allred DC. (1994). Breast Cancer Res. Treatment, 32, 39-47.
10. Fukasawa K, Choi T, Kuriyama R, Rulong S and Vande WG. (1996). Science, 271, 1744-1747.
11. Fukasawa K, Wiener F, Vande WG and Mai S. (1997). Oncogene, 15, 1295-1302.
12. Hundley JE, Koester SK, Troyer DA, Hilsenbeck SG, Subler MA and Windle JJ. (1997). Mol. Cell Biol., 17, 723-731.
13. Jacks T, Remington L, Williams BO, Schmitt EM, Halachmi S, Bronson RT and Weinberg RA. (1994). Curr. Biol., 4, 1-7.
14. Jerry DJ, Butel JS, Paulson EP, Cochran C, Wiseman RW, Donehower LA and Medina D. (1994). Mol. Carcinogen., 9, 175-183.
15. Jerry DJ, Kuperwasser C, Downing SR, Pinkas J, He C, Dickinson ES, Marconi S and Naber SP. (1998). Oncogene, 17, 2305-2312.
16. Kito K, Kihana T, Sugita A, Murao S, Akehi S, Sato M, Tachibana M, Kimura S and Ueda N. (1996). Mol. Carcinog., 17, 78-83.
17. Kumar R, Medina D and Sukumar S. (1990). Oncogene, 5, 1271-1277.
18. Lehman TA, Modali R, Boukamp P, Stanek J, Bennett WP, Welsch JA, Metcalf RA, Stampfer MR, Fusenig N, Rogan EM and Harris CC. (1993). Carcinogenesis, 14, 833-839.
19. Li B, Murphy KL, Laucirica R, Kittrell F, Medina D and Rosen JM. (1998). Oncogene, 16, 997-1007.
20. Li B, Rosen JM, McMenamin-Balano J, Muller WJ and Perkins AS. (1997). Mol. Cell. Biol., 17, 3155-3164.
21. Lundgren K, Montes de Oca Luna R, McNeill YB, Emerick EP, Spencer B, Barfield CR, Lozano G, Rosenberg MP and Finlay CA. (1997). Genes Dev., 11, 714-725.
22. Maroulakou IG, Shibata MA, Jorcyk CL, Chen XX and Green JE. (1997). Mol. Carcinog., 20, 168-174.
23. McCormack SJ, Weaver Z, Derning S, Natarajan G, Torri J, Johnson MD, Liyanage M, Ried T and Dickson RB. (1998). Oncogene, 16, 2755-2766.
24. McKenzie KE, Armstrong BA, Chen Y, Nagarajan M, Aldaz CM and Sukumar S. (1997). Mol. Carcinog., 20, 194-203.
25. Medina D. (1973). Meth. Cancer Res., 7, 3-53.
26. Medina D. (1974). J. Natl. Cancer Inst., 53, 213-221.
27. Medina D. (1982). Mammary tumors. In: Foster L, Small JD and Fox JG. (eds). The Mouse in Biomedical Research, Academic Press, New York, pp. 373-396.
28. Medina D. (1996). Mam. Gland Biol. Neoplasia, 1, 5-19.
29. Medina D and Smith GH. (1999). J. Natl. Cancer Inst., 91, 967-969.
30. Medina D, Stephens LC, Bonilla PJ, Hollmann A, Schwahn D, Kuperwasser C, Jerry DJ, Butel JS and Meyn RE. (1998). Mol. Carcinogen., 22, 199-207.
31. Muller WJ, Sinn E, Pattengale PK, Wallace R and Leder P. (1988). Cell, 54, 105-115.
32. Peto R. (1974). Br. J. Cancer, 29, 101-105.
33. Qing WG, Conti CJ, LaBate M, Johnston D, Slaga TJ and MacLeod MC. (1997). Carcinogenesis, 18, 553-559.
34. Ritland SR, Rowse GJ, Chang Y and Gendler SJ. (1997). Cancer Res., 57, 3520-3525.
35. Ross JA and Nesnow S. (1999). Mutat. Res., 424, 155-166.
36. Russo J, Gusterson BA, Rogers AE, Russo IH, Wellings SR and van Zwieten MJ. (1990). Lab. Invest., 62, 244-278,
37. Sivaraman L, Stephens LC, Markaverich BM, Clark JA, Krnacik S, Conneely OM, O'Malley BW and Medina D. (1998). Carcinogenesis, 19, 1573-1581.
38. Tzeng Y-J, Guhl E, Graessmann M and Graessmann A. (1993). Oncogene, 8, 1965-1971.
39. Tzeng YJ, Zimmermann C, Guhl E, Berg B, Avantaggiati ML and Graessmann A. (1998). Oncogene, 16, 2103-2114.
40. Wellings SR, Jensen HM and Marcum RG. (1975). J. Natl. Cancer Inst., 55, 231-271.